alprostadil
PolandDrugs containing this active substance
-
The medicinal product is intended for patients with stage III chronic peripheral arterial disease, for whom other treatment methods (revascularization) are not possible or have proven ineffective.
Form: solution for infusion, powder for preparation of
Active substance Dosage alprostadil 60 mcg ATC: C01EA01
Manufacturer: Aesica Pharmaceuticals GmbH
-
The medicine is used for maintenance treatment in newborns with congenital heart defects. Its purpose is to temporarily maintain the patency of the ductus arteriosus, which allows the child to survive until cardiac surgery can be performed.
Form: solution for injection
Active substance Dosage alprostadil 500 mcg/ml ATC: C01EA01
Manufacturer: Pfizer Manufacturing Belgium NV